Summary

Overview
Global Flow Diverters Market reached US$ XX billion in 2022 and is expected to reach US$ XX billion by 2030, growing with a CAGR of XX% during the forecast period 2023-2030.
Flow diversion is a technique in which your surgeon uses a catheter to place a stent (a soft, flexible mesh tube) into the blood vessel where an aneurysm has formed. This process immediately diverts the flow of blood away from the aneurysm itself. The increase in the launches and technological advancements of devices drive market growth.
The North America region is expected to hold a significant position in the market share. The increase in the number of launches by the key companies is expected to hold the region in the dominant position. Surpass flow diverter segment holds a significant market share. The advantage of the device over the other types is holding the segment in the dominant market share.
Dynamics
Rise in the Number of Launches of the Products will Accelerate the Market Growth
An increased number of product launches and an increase in technological advancements will drive market growth. For instance, on June 1, 2022, Medtronic, a wholly owned subsidiary of Medtronic plc, launched a CE-marked fourth-generation flow diverter, Pipeline Vantage with Shield Technology, for the endovascular treatment of brain aneurysms. Pipeline Vantage with Shield Technology is a new flow diverter with enhanced design features for both the delivery system and implant.
On October 20, 2021, Evasc Neurovascular developed the third generation of its eCLIPs device, the eCLIPs Bifurcation Flow Diverter. The new device is classified as a flow diverter, with a leaf density of 35%, which is 60% higher than the existing eCLIPs devices. Thus, an increase in the number of launches and advancements of the products will drive the market growth.
Increase in the Prevalence of Brain Aneurysm Cases will Elevate the Market Growth
An increase in the number of brain aneurysm cases is driving the growth of the market. For instance, according to the Brain Aneurysm Foundation, the annual rupture rate is approximately 8 – 10 per 100,000 people. About 30,000 people in the United States suffer a brain aneurysm rupture each year.
A brain aneurysm ruptures every 18 minutes. Almost 500,000 deaths worldwide each year are caused by brain aneurysms, and half the victims are younger than 50. Brain aneurysms are most prevalent in people ages 35 to 60 but can also occur in children. Most aneurysms develop after the age of 40. Ruptured brain aneurysms account for 3-5% of all new strokes. Thus, an increase in aneurysm cases will drive the growth of the market in the forecast period.
Complications Associated with Flow Diverters can Decline the Market Growth
The complications associated with using flow diverters can cause a decline in market growth. The majority of flow diverter complications occurred during the perioperative period. Thromboembolic complications in flow diversion include acute and hyperacute stent thrombosis, large-vessel occlusion, and perforator or side-branch occlusion.
Complications include hematoma (blood clot collection at the groin) and hemorrhagic or ischemic stroke, which can be minor or major. There are risks associated with flow diverters, including in-stent thrombosis, perianeurysmal edema, distant and delayed hemorrhages, and perforator occlusions.
Segment Analysis
The global flow diverters market is segmented based on type, material, application, end-user and region.
Surpass Flow Diverter Segment Holds a Significant Position in the Market Share
Surpass flow diverter segment holds a dominant market share due to the benefits and advantages of the devices over the rest. The surpass flow diverters are more advantageous because they provide a better aneurysm occlusion, lower complication rate, and improved long-term outcomes compared to the other devices.
Surpass flow diverters are mostly used in complex conditions to divert the blood flow away from the aneurysms. The Surpass Streamline flow diverter (SSFD) possesses four attributes that may offer an important advantage in the treatment of complex pathologies, including utilization of an over-the-wire (OTW) delivery system, greater device length, larger potential diameter, and propensity to open in tortuosity. Thus, the advantages of the device hold the dominant market share in the forecast period.
Geographical Penetration
North America region holds the largest market share in the global flow diverters market
The increase in the number of launches in the region holds the market’s dominant share. With the presence of major companies and the demand for treating aneurysm disease conditions, the launches have been increasing.
On March 1, 2023, PT Healthcare has conducted a workshop. And has launched the DERIVO 2 Embolisation Device. The DERIVO2 Embolisation Device is the next generation of the proven and reliable flow diverter optimized for different treatment options. Thus, the increase in the launches of the products will drive the growth of the region’s market share.
COVID-19 Impact Analysis
The outbreak of the COVID-19 pandemic in late 2019 created unprecedented challenges for industries worldwide, including the global flow diverters market. COVID-19 pandemic caused disruption in consultation for diseases such as cerebral aneurysms and hypertension. The delayed consultations have impacted the treatment processes and, thus, impacted the market growth.
The delay in manufacturing the flow diverters by the key companies and the lack of investments by the partner companies have significantly impacted the market growth. Thus, COVID-19 has impacted the market growth negatively. Thus, this factor was anticipated to restrain the demand for flow diverter devices and restrain the market growth.

By Type
• Pipeline Embolization Device
• Silk Flow Diverter
• Surpass Flow Diverter
• Flow Redirection Endoluminal Device
By Material
• Cobalt-Chromium
• Nitinol-Alloy
• Others
By Application
• Cerebral Aneurysms
• Multiple Intracranial Aneurysms
• Others
By End-User
• Hospitals
• Ambulatory Surgical Centers
• Specialty Clinics
• Others
By Region
• North America
o U.S.
o Canada
o Mexico
• Europe
o Germany
o UK
o France
o Italy
o Spain
o Rest of Europe
• South America
o Brazil
o Argentina
o Rest of South America
• Asia-Pacific
o China
o India
o Japan
o Australia
o Rest of Asia-Pacific
• Middle East and Africa
Competitive Landscape
The global flow diverters market is fragmented, with the presence of many local and international players including Medtronic, Balt Extrusion Sa, Phenhttps, Phenox Gmbh, Acandis Gmbh, MicroPort Scientific Corporation, MicroVention Inc., Cerus Endovascular Inc., Evasc Neurovascular Enterprises etc. are the leading companies with a significant market share.
Why Purchase the Report?
• To visualize the global flow diverters market segmentation based on type, material, application, end-user and region as well as understand key commercial assets and players.
• Identify commercial opportunities by analyzing trends and co-development.
• Excel data sheet with numerous data points of flow diverters market-level with all segments.
• PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
• Product mapping available as excel consisting of key products of all the major players.
The global flow diverters market report would provide approximately 61 tables, 58 figures, and 186 Pages.
Target Audience 2023
• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies

ページTOPに戻る

Table of Contents

1. Methodology and Scope
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. Definition and Overview
3. Executive Summary
3.1. Snippet by Type
3.2. Snippet by Material
3.3. Snippet by Application
3.4. Snippet by End-User
3.5. Snippet by Region
4. Dynamics
4.1. Impacting Factors
4.1.1. Drivers
4.1.1.1. Rise in the number of launches of the products
4.1.1.2. Increase in the prevalence of brain aneurysm
4.1.2. Restraints
4.1.2.1. Complications associated with flow diverters
4.1.3. Opportunity
4.1.4. Impact Analysis
5. Industry Analysis
5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
5.5. Russia-Ukraine War Impact Analysis
5.6. DMI Opinion
6. COVID-19 Analysis
6.1. Analysis of COVID-19
6.1.1. Scenario Before COVID
6.1.2. Scenario During COVID
6.1.3. Scenario Post COVID
6.2. Pricing Dynamics Amid COVID-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During Pandemic
6.5. Manufacturers Strategic Initiatives
6.6. Conclusion
7. By Type
7.1. Introduction
7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
7.1.2. Market Attractiveness Index, By Type
7.2. Pipeline Embolization Device *
7.2.1. Introduction
7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Silk Flow Diverter
7.4. Surpass Flow Diverter
7.5. Flow Redirection Endoluminal Device
8. By Material
8.1. Introduction
8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
8.1.2. Market Attractiveness Index, By Material
8.2. Cobalt-Chromium *
8.2.1. Introduction
8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Nitinol-Alloy
8.4. Others
9. By Application
9.1. Introduction
9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
9.1.2. Market Attractiveness Index, By Application
9.2. Cerebral Aneurysms *
9.2.1. Introduction
9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Multiple Intracranial Aneurysms
9.4. Others
10. By End-User
10.1. Introduction
10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
10.1.2. Market Attractiveness Index, By End-User
10.2. Hospitals *
10.2.1. Introduction
10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
10.3. Ambulatory Surgical Centers
10.4. Specialty Clinics
10.5. Others
11. By Region
11.1. Introduction
11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
11.1.2. Market Attractiveness Index, By Region
11.2. North America
11.2.1. Introduction
11.2.2. Key Region-Specific Dynamics
11.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
11.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
11.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
11.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
11.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
11.2.7.1. U.S.
11.2.7.2. Canada
11.2.7.3. Mexico
11.3. Europe
11.3.1. Introduction
11.3.2. Key Region-Specific Dynamics
11.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
11.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
11.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
11.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
11.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
11.3.7.1. Germany
11.3.7.2. UK
11.3.7.3. France
11.3.7.4. Italy
11.3.7.5. Spain
11.3.7.6. Rest of Europe
11.4. South America
11.4.1. Introduction
11.4.2. Key Region-Specific Dynamics
11.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
11.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
11.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
11.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
11.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
11.4.7.1. Brazil
11.4.7.2. Argentina
11.4.7.3. Rest of South America
11.5. Asia-Pacific
11.5.1. Introduction
11.5.2. Key Region-Specific Dynamics
11.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
11.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
11.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
11.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
11.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
11.5.7.1. China
11.5.7.2. India
11.5.7.3. Japan
11.5.7.4. Australia
11.5.7.5. Rest of Asia-Pacific
11.6. Middle East and Africa
11.6.1. Introduction
11.6.2. Key Region-Specific Dynamics
11.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
11.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
11.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
11.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
12. Competitive Landscape
12.1. Competitive Scenario
12.2. Market Positioning/Share Analysis
12.3. Mergers and Acquisitions Analysis
13. Company Profiles
13.1. Stryker Corporation *
13.1.1. Company Overview
13.1.2. Product Portfolio and Description
13.1.3. Financial Overview
13.1.4. Key Developments
13.2. Medtronic
13.3. Balt Extrusion Sa
13.4. Phenhttps
13.5. Phenox Gmbh
13.6. Acandis Gmbh
13.7. MicroPort Scientific Corporation
13.8. MicroVention Inc.
13.9. Cerus Endovascular Inc.
13.10. Evasc Neurovascular Enterprises
LIST NOT EXHAUSTIVE
14. Appendix
14.1. About Us and Services
14.2. Contact Us